The Newsroom

Hyderabad, October 19, 2026: Sai Life Sciences (BSE: 544306 | NSE: SAILIFE) has once again earned the Great Place To […]

Hyderabad: Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), has […]

Sai Life Sciences brought its scientific community together for the Sai Science Symposium 2026, a day dedicated to scientific excellence, […]

In a feature titled “India’s Race for the CDMO Crown,” published by Express Pharma, Tuneer Ghosh, President – CMC at […]

Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), has released […]

Understanding what happens to therapeutic antibodies and antibody-drug conjugates (ADCs) after they enter a cell is critical to designing targeted […]

Sai Life Sciences plans to set up a new oral solid formulation facility to support small-molecule programs entering early clinical […]

We have successfully scaled up a late-stage GMP intermediate for a large pharmaceutical customer using flow chemistry, marking another step […]

A recent publication from Sai Life Sciences highlights our work on a three-dimensional hepatic spheroid-array system for the assessment of […]

Sai Life Sciences is seeing increasing opportunities to deepen and expand customer relationships through dedicated Full-Time Equivalent (FTE) engagement models, […]

Sai Life Sciences has inaugurated the first facility within its new Unit VIII campus in Hyderabad’s Genome Valley, marking an […]